RadNet, Inc. (RDNT): Price and Financial Metrics
RadNet, Inc. (RDNT)
Today's Latest Price: $19.04 USD
Updated Dec 2 4:00pm
Add RDNT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
RDNT Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for RDNT is 6.77 -- better than 95.1% of US stocks.
- Of note is the ratio of RadNet Inc's sales and general administrative expense to its total operating expenses; merely 0.47% of US stocks have a lower such ratio.
- For RDNT, its debt to operating expenses ratio is greater than that reported by 96.24% of US equities we're observing.
- If you're looking for stocks that are quantitatively similar to RadNet Inc, a group of peers worth examining would be SNR, STNG, FCPT, GTN, and BRG.
- RDNT's SEC filings can be seen here. And to visit RadNet Inc's official web site, go to www.radnet.com.
RDNT Stock Price Chart Interactive Chart >
RDNT Price/Volume Stats
| Current price | $19.04 | 52-week high | $23.45 |
| Prev. close | $18.77 | 52-week low | $5.81 |
| Day low | $18.27 | Volume | 182,945 |
| Day high | $19.23 | Avg. volume | 335,221 |
| 50-day MA | $16.81 | Dividend yield | N/A |
| 200-day MA | $15.64 | Market Cap | 983.15M |
RadNet, Inc. (RDNT) Company Bio
RadNet, Inc. provides outpatient diagnostic imaging services in the United States. The company was founded in 1985 and is based in Los Angeles, California.
RDNT Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $19.04 | $73.51 | 302% |
Below please find a table outlining a discounted cash flow forecast for RDNT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that RadNet Inc ranked in the 74th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for RadNet Inc ended up being:
- 45% of the company's capital comes from equity, which is greater than merely 20.14% of stocks in our cash flow based forecasting set.
- RadNet Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
- Relative to other stocks in its sector (Healthcare), RadNet Inc has a reliance on debt greater than 89.59% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 294% |
| 1% | 298% |
| 2% | 302% |
| 3% | 306% |
| 4% | 310% |
| 5% | 314% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RDNT, try CSTL, MYL, UHS, CI, and ABBV.
Loading social stream, please wait...